Kratom, with its many health benefits, such as lessening the symptoms of opiate withdrawal and helping with depression, is emerging as a high-potential therapeutic option today. Its therapeutic benefits closely resemble those of cannabidiol (CBD), and it is expected to follow the same route forced by hemp and associated products.
We are at a Defining Moment for the Kratom Industry
The value of the kratom industry is estimated to be between $1.2 and $5 billion. Between 2014 and 2016, approximately 121,254 pounds of kratom entered the US market, and this quantity is expected to increase as more benefits of kratom are revealed. However, concerns have been rife that incidents of high concentrations of nickel, lead, and salmonella contamination could derail the expected growth of the kratom industry.
Taking caution, perhaps after seeing the rough and lengthy route followed by hemp, manufacturers who deal with kratom only want what is clean and safe. As a result, with its advanced analytical instrumentation and expertise, Sante Laboratories is heavily involved in the manufacture of kratom in the United States.
The only way to ensure that kratom getting into the market is safe, effective, and free from contaminants is through proper and consistent testing in an accredited lab.
The risks associated with kratom have made some states, such as Indiana and Wisconsin, to ban its products. This is why the industry is at a critical point in defining the right path for growth.
To address this, Sante Laboratories wants to help shape the industry’s future by assisting in crafting the testing procedures, developing the safety profiles, and the right dosages. With these guidelines, it will become easy to reap the benefits of kratom.
The Growth Potential of the Kratom Industry
Today, the multi-billion opioid dependence has made researchers to set off looking for a solution, and kratom is emerging as one of the top alternatives. The main ingredient in kratom is 7-hydroxymitragynine, which works through binding to the body’s opioid receptors to deliver the anticipated therapeutic effects. 7-hydroxymitragynine has been demonstrated to be about 43 times more potent than morphine.
To reap the huge potential of this alkaloid, it is prudent to set the right limits, and Sante Laboratories already have something to put on the table. When testing kratom, Sante has put a limit of 2% 7-hydroxymitragynine for all the materials it tests.
Although heavy metals are not inherent to kratom, lack of proper oversight could raise the risk of unhealthy exposure. Therefore, it is paramount that the raw materials are tested for heavy metals impurities before getting into the United States supply chain.
Such analysis should only be done by an ISO/IEC 17025:2017 accredited laboratory, such as Sante Laboratories, and a certificate of analysis (COA) issued. The certificate is used to verify the compliance of the material with heavy metal limits, as outlined in the American Herbal Products Associations (AHPA) compendiums.
Sante Laboratories: Your Partner for Testing Precision and Accuracy
Sante Laboratories is an ISO/IEC 17025:2017 accredited facility, which has a combined 35 years of experience in analytical chemistry, drug development, and pharmaceutical sciences. To help the kratom industry to grow, they want to assist in building its standards through:
- Label compliance.
- GMP protocols.
- Testing guidelines.
- Bioanalytical essays.
Sante is one of the few accredited laboratories for testing alkaloids that are found in kratom, such as mitragynine and 7-hydroxymitragynine. By using Thermo Fisher’s most advanced Ultra-High Performance Liquid Chromatography instruments, Sante is the only lab in the globe that can test up to seven alkaloids; most labs only test for two.
With greater precision and testing accuracy, Sante Laboratories will also help develop more innovative research methods about kratom. This is the foundation that kratom industry needs for growth and to help more people enjoy its therapeutic benefits. Because the health benefits of kratom are numerous.